ANDREW KELLEY: Open Payments
NPI 1356930325 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 46 payments from 13 companies in 2025. Trend: 2023 $2,137 · 2024 $1,670 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Dexcom, Inc. | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| PFIZER INC. | 1 | $29 |
| Exact Sciences Corporation | 1 | $22 |
Products named: Kerendia, JARDIANCE, Wegovy, XIFAXAN, TRELEGY ELLIPTA, Dexcom G6 Transmitter, AIRSUPRA, BREZTRI.
Industry payments across TX — which companies pay providers there.
